|
Market Closed -
Euronext Dublin
18:55:00 04/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 7.000 EUR | 0.00% |
|
0.00% | -9.09% |
| 08-26 | Malin swings to interim profit as finance income rises and costs fall | AN |
| 02-26 | EARNINGS AND TRADING: Connecting Excellence hails record January fees | AN |
| Market Cap | 30.35M 35.27M 28.55M 26.08M 48.79M 3.33B 48.92M 337M 131M 1.71B 132M 130M 5.5B | P/E 2024 * |
-
| P/E 2025 | -8.37x |
|---|---|---|---|---|---|
| Enterprise Value | 17.45M 20.27M 16.41M 14.99M 28.05M 1.91B 28.13M 194M 75.27M 982M 76.13M 74.47M 3.16B | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
63.83% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 month | -1.41% | ||
| 3 months | -7.89% | ||
| 6 months | -9.09% | ||
| Current year | -9.09% |
| 1 week | 7 |  | 7 |
| 1 month | 6.8 | | 7.1 |
| Current year | 6.8 | | 8.45 |
| 1 year | 6.8 | | 9.3 |
| 3 years | 3.84 | | 10.4 |
| 5 years | 3.59 | | 10.4 |
| 10 years | 1.4 | | 14 |
| Manager | Title | Age | Since |
|---|---|---|---|
Andrea Stafford
DFI | Director of Finance/CFO | 56 | 01/05/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
William Daniel
CHM | Chairman | 73 | 02/08/2019 |
| Director/Board Member | 67 | 16/07/2018 | |
Rudy Mareel
BRD | Director/Board Member | 63 | 16/07/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/2/26 A | Exercice | 10,307 | 0.2382% | |||
| 5/28/25 A | Exercice | Chief Executive Officer | 5,746 | 0.1328% | ||
| 4/7/25 A | Sell | Director | 11,075 | 0.2560% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | -12.50% | +59.09% | 35.27M | |
| -0.88% | -2.15% | +58.05% | +105.91% | 1,024B | |
| -1.15% | +2.68% | +54.25% | +71.29% | 663B | |
| -1.44% | +0.38% | +20.65% | +75.54% | 453B | |
| +0.14% | -0.47% | +30.20% | +40.61% | 352B | |
| -1.33% | +4.72% | +24.62% | +47.60% | 304B | |
| -1.15% | +0.30% | -0.69% | +11.83% | 252B | |
| -1.55% | +1.11% | +54.15% | +72.13% | 236B | |
| -0.88% | +1.15% | -14.60% | -54.84% | 206B | |
| -0.15% | +3.65% | +31.24% | +100.90% | 187B | |
| Average | -0.84% | +0.98% | +24.54% | +53.01% | 367.84B | |
| Weighted average by Cap. | -0.96% | +0.55% | +37.63% | +67.00% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | - | -6.9M -8.02M -6.49M -5.93M -11.09M -757M -11.12M -76.71M -29.77M -388M -30.11M -29.45M -1.25B |
| Net Debt | -62.1M -72.17M -58.43M -53.37M -99.85M -6.81B -100M -690M -268M -3.5B -271M -265M -11.26B | -12.9M -14.99M -12.14M -11.09M -20.74M -1.42B -20.8M -143M -55.65M -726M -56.29M -55.07M -2.34B |
Employees
2
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/09/26 | €7.000 | 0.00% | 4 |
| 03/09/26 | €7.000 | 0.00% | 0 |
| 02/09/26 | €7.000 | 0.00% | 0 |
| 01/09/26 | €7.000 | 0.00% | 0 |
| 31/08/26 | €7.000 | 0.00% | 20 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
7.000EUR
Average target price
15.50EUR
Spread / Average Target
+121.43%
- Stock Market
- Stocks
- MLC Stock
Select your edition
All financial news and data tailored to specific country editions
